HK1165675A1 - 治療沙粒病毒感染的亞氨糖類和方法 - Google Patents

治療沙粒病毒感染的亞氨糖類和方法

Info

Publication number
HK1165675A1
HK1165675A1 HK12106531.9A HK12106531A HK1165675A1 HK 1165675 A1 HK1165675 A1 HK 1165675A1 HK 12106531 A HK12106531 A HK 12106531A HK 1165675 A1 HK1165675 A1 HK 1165675A1
Authority
HK
Hong Kong
Prior art keywords
iminosugars
treating
methods
arenaviral
infections
Prior art date
Application number
HK12106531.9A
Other languages
English (en)
Inventor
Urban Ramstedt
Brennan Klose
Nicole Zitzmann
Raymond A Dwek
Terry D Butters
Original Assignee
United Therapeutics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Therapeutics Corp filed Critical United Therapeutics Corp
Publication of HK1165675A1 publication Critical patent/HK1165675A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
HK12106531.9A 2009-02-24 2012-07-04 治療沙粒病毒感染的亞氨糖類和方法 HK1165675A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20239109P 2009-02-24 2009-02-24
US27225109P 2009-09-04 2009-09-04
PCT/US2010/024914 WO2010099064A1 (en) 2009-02-24 2010-02-22 Iminosugars and methods of treating arenaviral infections

Publications (1)

Publication Number Publication Date
HK1165675A1 true HK1165675A1 (zh) 2012-10-12

Family

ID=42665853

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12106531.9A HK1165675A1 (zh) 2009-02-24 2012-07-04 治療沙粒病毒感染的亞氨糖類和方法

Country Status (9)

Country Link
US (1) US20100222384A1 (zh)
EP (1) EP2400843B1 (zh)
JP (1) JP5951996B2 (zh)
KR (2) KR20170117614A (zh)
CN (1) CN102625660B (zh)
CA (1) CA2753194A1 (zh)
ES (1) ES2562635T3 (zh)
HK (1) HK1165675A1 (zh)
WO (1) WO2010099064A1 (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096764A1 (en) 2009-02-23 2010-08-26 United Therapeutics Corporation Iminosugars and methods of treating viral diseases
KR20150035767A (ko) 2012-06-06 2015-04-07 유니터 바이롤로지, 엘엘씨 신규 이미노당 및 그의 용도
CN102775384B (zh) * 2012-07-27 2015-05-27 中国科学院化学研究所 小钩树碱i和j类似物及其制备方法与应用
WO2014179438A2 (en) * 2013-05-02 2014-11-06 The Chancellor, Masters And Scholars Of The University Of Oxford Glycolipid inhibition using iminosugars
WO2015039010A2 (en) 2013-09-16 2015-03-19 Unither Virology, Llc Deoxynojirimycin derivatives and methods of their using
IT202000008917A1 (it) * 2020-04-24 2021-10-24 Biovalley Invest Partner S R L Composizioni antivirali

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
DE2834122A1 (de) * 1978-08-03 1980-02-14 Bayer Ag Verfahren zur herstellung von 6-amino-6-desoxy-l-sorbose
DE2839309A1 (de) * 1978-09-09 1980-03-27 Bayer Ag 3,4,5-trihydroxypiperidin-derivate
DE2853573A1 (de) * 1978-12-12 1980-07-03 Bayer Ag Herstellung von n-substituierten derivaten des l-desoxynojirimycins
DE3038901A1 (de) * 1980-10-15 1982-05-06 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von n-substituierten derivaten des 1-desoxynojirimycins
DE3611841A1 (de) * 1986-04-09 1987-10-15 Bayer Ag Verfahren zur herstellung von 1-desoxynojirimycin und dessen n-derivaten
US5043273A (en) * 1989-08-17 1991-08-27 Monsanto Company Phosphorylated glycosidase inhibitor prodrugs
US5103008A (en) * 1989-08-17 1992-04-07 Monsanto Company Compound, N-butyl-deoxynojirimycin-6-phosphate
US4994572A (en) * 1989-10-12 1991-02-19 Monsanto Company Synthesis of nojirimycin derivatives
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement
US5200523A (en) * 1990-10-10 1993-04-06 Monsanto Company Synthesis of nojirimycin derivatives
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5399567A (en) * 1993-05-13 1995-03-21 Monsanto Company Method of treating cholera
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
AU761748B2 (en) * 1997-12-11 2003-06-12 Chancellor, Masters And Scholars Of The University Of Oxford, The Inhibition of membrane-associated viral replication
US6689759B1 (en) * 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
US6610703B1 (en) * 1998-12-10 2003-08-26 G.D. Searle & Co. Method for treatment of glycolipid storage diseases
GB9828474D0 (en) * 1998-12-24 1999-02-17 British Aerospace Surface topology inspection
US6545021B1 (en) * 1999-02-12 2003-04-08 G.D. Searle & Co. Use of substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infections
GB0100889D0 (en) * 2001-01-12 2001-02-21 Oxford Glycosciences Uk Ltd Compounds
JP2003505430A (ja) * 1999-07-26 2003-02-12 ジー・ディー・サール・アンド・カンパニー デオキシノジリマイシンの長鎖ｎ−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用
US7256005B2 (en) * 1999-08-10 2007-08-14 The Chancellor, Masters And Scholars Of The University Of Oxford Methods for identifying iminosugar derivatives that inhibit HCV p7 ion channel activity
US6565487B1 (en) * 2000-07-17 2003-05-20 Hai Pin Kuo Exerciser having a forward and rearward adjusting seat
CA2814774C (en) * 2003-01-31 2016-03-22 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiency disorders
US7446098B2 (en) * 2003-02-18 2008-11-04 Mount Sinai School Of Medicine Of New York University Combination therapy for treating protein deficiencies
US20060211752A1 (en) * 2004-03-16 2006-09-21 Kohn Leonard D Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
US20050256168A1 (en) * 2004-04-28 2005-11-17 Block Timothy M Compositions for oral administration for the treatment of interferon-responsive disorders
US7524829B2 (en) * 2004-11-01 2009-04-28 Avi Biopharma, Inc. Antisense antiviral compounds and methods for treating a filovirus infection
GB0501352D0 (en) * 2005-01-21 2005-03-02 Slingsby Jason H Use of glycosylation modulators in combination with membrane fusion inhibitors for treatment of infections caused by viruses bearing glycosylated envelope
JP2008533175A (ja) * 2005-03-16 2008-08-21 ユニバーシティ・オブ・オックスフォード Ｈｉｖ−１のためのマンノース免疫原
CN101355971A (zh) * 2005-05-17 2009-01-28 阿米库斯治疗学公司 使用1-去氧野尻霉素衍生物治疗庞皮病的方法
EP3782655A1 (en) * 2005-05-17 2021-02-24 Amicus Therapeutics, Inc. A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
KR20080033463A (ko) * 2005-07-27 2008-04-16 유니버시티 오브 플로리다 리서치 파운데이션, 아이엔씨. 단백질 미스폴딩을 보정하는 작은 화합물 및 그의 용도
NZ565954A (en) * 2005-07-27 2012-03-30 Univ Florida Use of heat shock inducing compound and an agent that increases stem cell mobilization int he manufacture of a medicament to treat ocular disease
US20070244184A1 (en) * 2006-01-09 2007-10-18 Simon Fraser University Glycosidase inhibitors and methods of synthesizing same
JP2009538276A (ja) * 2006-04-24 2009-11-05 アカデミッシュ メディシュ セントラム 嚢胞性線維症の改良型治療
JP5241709B2 (ja) * 2006-05-24 2013-07-17 ユナイテッド セラピューティクス コーポレーション デオキシノジリマイシンおよびｄ−アラビニトールのアナログおよび使用方法
EP2399587A1 (en) * 2006-08-02 2011-12-28 The University of Oxford Liposome treatment of viral infections
CA2666814A1 (en) * 2006-08-21 2008-05-29 United Therapeutics Corporation Combination therapy for treatment of viral infections
EP2282723A2 (en) * 2008-03-26 2011-02-16 University of Oxford Endoplasmic reticulum targeting liposomes
WO2010027996A1 (en) * 2008-09-02 2010-03-11 Institute For Hepatitis And Virus Research Novel imino sugar derivatives demonstrate potent antiviral activity and reduced toxicity

Also Published As

Publication number Publication date
EP2400843A4 (en) 2012-01-04
ES2562635T3 (es) 2016-03-07
JP5951996B2 (ja) 2016-07-13
WO2010099064A1 (en) 2010-09-02
CN102625660A (zh) 2012-08-01
CA2753194A1 (en) 2010-09-02
EP2400843B1 (en) 2015-11-11
KR20120042718A (ko) 2012-05-03
JP2012518648A (ja) 2012-08-16
KR20170117614A (ko) 2017-10-23
CN102625660B (zh) 2015-03-11
KR101787434B1 (ko) 2017-11-15
US20100222384A1 (en) 2010-09-02
EP2400843A1 (en) 2012-01-04

Similar Documents

Publication Publication Date Title
AP3269A (en) Methods and compounds for treating paramyxoviridaevirus infections
EP2512369A4 (en) GRAFT DEVICES AND METHODS OF USE
PL2493698T3 (pl) Urządzenia zabezpieczające i sposoby ich wytwarzania
EP2603202A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF TAUOPATHIES
IL208354A0 (en) Methods of treatment
EP2490530A4 (en) COMPOUNDS AND METHOD FOR THE TREATMENT OF BACTERIAL INFECTIONS
HK1162366A1 (zh) 用於治療和/或預防疾病的裝置和方法
IL217292A0 (en) Polypeptides and method of treatment
EP2498798A4 (en) COMPOSITIONS AND METHODS OF WOUND TREATMENT
GB0908507D0 (en) Hyperbaric dessing and method
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2440205A4 (en) IMINO SUGAR UDN METHOD FOR THE TREATMENT OF BUNYAVIRAL AND TOGAVIRAL DISEASES
EP2521554A4 (en) SUBSTANCES AND METHODS FOR THE PREVENTION AND TREATMENT OF VIRAL INFECTIONS
EP2416108A4 (en) SPARKING PROCESSING AND SPARKING DEVICE
EP2473046A4 (en) IMINOSUCRES AND METHODS OF TREATING FILOVIRAL DISEASES
DK2473482T3 (en) Methods of treating orthomyxoviral infections
EP2416107A4 (en) SPARKING PROCESSING AND SPARKING DEVICE
HK1193379A1 (zh) 修復組合物和處理方法
HK1165675A1 (zh) 治療沙粒病毒感染的亞氨糖類和方法
HK1165221A1 (zh) 亞胺糖和治療病毒疾病的方法
EP2473493A4 (en) METHODS OF TREATING POXVIRAL INFECTIONS
PL2424559T3 (pl) Sposoby leczenia zakażeń bakteryjnych z zastosowaniem orytawancyny
EP2427129A4 (en) DEVICES AND METHODS FOR MODIFYING FABRICS
EP2456437A4 (en) COMBINATION THERAPY FOR TAUOPATHIES
EP2512504A4 (en) COMPOSITION AND THERAPEUTIC METHOD

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200224